Viking Therapeutics, Inc. ($VKTX)
Filing Information
| Accession Number | 0001193125-26-100581 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 10, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
4,475
Total Value
$149,912.50
P&L
-3.5% ($5,235.75)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock, par value $0.00001 per share | โ | Mar 10, 2026 | Purchase | 4,475 | $33.50 | $149,912.50 | 4,475 | Direct | โ | View Details |